Clinical Trial Update: Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease [Phase 2]

View source ↗

Summary

This clinical trial evaluated the effect of etavopivat on cerebral hemodynamic responses in children with sickle cell disease; the Phase 2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED